Target intelligence / Profile preview

Pro-inflammatory cytokines and chemokines

Molecular classification
Cytokine, Chemokine, Signaling protein
01

Overview

Pro-inflammatory cytokines and chemokines are a broad category of small signaling proteins secreted primarily by immune cells like macrophages, T-cells, and B-cells, as well as endothelial cells and fibroblasts. They function as key mediators of the innate and adaptive immune responses, facilitating cell-to-cell communication and directing the migration of leukocytes to sites of injury or infection through chemotaxis (StatPearls, 2023). Common examples include Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Interleukin-8 (IL-8/CXCL8). Dysregulation or overproduction of these molecules is central to the pathogenesis of chronic inflammatory diseases, autoimmune conditions, and acute systemic inflammatory responses like cytokine release syndrome (Nature Reviews Immunology, 2018). Pharmacological intervention typically involves the use of monoclonal antibodies, decoy receptors, or small molecule inhibitors to neutralize the ligands or block their receptors, thereby dampening the inflammatory cascade. However, because these proteins are essential for normal host defense, their inhibition carries risks such as increased susceptibility to opportunistic infections and impaired wound healing (PubMed, 2021).

Other names
Inflammatory cytokinesPro-inflammatory mediatorsInflammatory chemokinesPro-inflammatory factors
02

Mechanism of action

Neutralization of circulating ligands, competitive inhibition of cytokine receptors, and inhibition of downstream signaling pathways.

03

Biological functions

Immune responseInflammationChemotaxisCell signalingHematopoiesis
04

Disease associations

Rheumatoid arthritisInflammatory bowel diseasePsoriasisSepsisCytokine release syndromeCancerNeuroinflammation
05

Safety considerations

Increased risk of serious infectionsReactivation of latent tuberculosisIncreased risk of malignancy (e.g., lymphoma)Injection site or infusion reactionsNeutropenia
06

Interacting drugs

Infliximab

7 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)Interleukin-6 (IL-6) levelsTumor Necrosis Factor-alpha (TNF-α) levelsProcalcitonin

Beyond the preview

Go deeper on Pro-inflammatory cytokines and chemokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-inflammatory cytokines and chemokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call